CytomX Therapeutics
CTMX
CTMX
110 hedge funds and large institutions have $236M invested in CytomX Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 27 increasing their positions, 44 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
110
Holders Change
-4
Holders Change %
-3.51%
% of All Funds
1.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
21
Increased
27
Reduced
44
Closed
25
Calls
$238K
Puts
$287K
Net Calls
-$49K
Net Calls Change
+$164K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$25.1M |
| 2 |
RI
RTW Investments
New York
|
$26.1M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
$10.4M |
| 4 |
O
OrbiMed
New York
|
$13.9M |
| 5 |
Millennium Management
New York
|
$5.49M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Zurich Cantonal Bank
Zurich,
Switzerland
| – | -$30K | -5,922 | Closed |
|
127
Macquarie Group
Sydney, NSW 2000,
Australia
| – | -$25K | -4,853 | Closed |
|
|
MCM
128
Manchester Capital Management
Manchester,
Vermont
| – | -$16K | -3,239 | Closed |
|
|
FQ
129
First Quadrant
Glendale,
California
| – | -$16K | -3,100 | Closed |
|
130
Canada Life
Winnipeg,
Manitoba, Canada
| – | -$13K | -2,623 | Closed |
|
|
PCM
131
Penserra Capital Management
Orinda,
California
| – | -$7K | -1,490 | Closed |
|
|
LWM
132
Liberty Wealth Management
Oakland,
California
| – | -$3K | -500 | Closed |
|